Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FG1UT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,902
Award facts
- Contract value 100% obligated
- $16,902.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,902.19 to AmerisourceBergen Drug Corp for the supply of Zepbound (tirzepatide) 15 mg/0.5 ml pens on December 3, 2025. This firm fixed-price delivery order, which concludes on December 4, 2025, was competitively awarded without set-aside restrictions. The pharmaceutical product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the contractor to supply military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor specializing in brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's extensive portfolio of DLA contract awards demonstrates its capability to fulfill competitive federal procurement requirements for pharmaceutical products supporting military and veteran healthcare systems. The Zepbound delivery order represents a discrete pharmaceutical supply need within the broader scope of AmerisourceBergen's comprehensive global pharmaceutical prime vendor relationship with DLA.
Quick answers
Who was awarded contract SPE2DR26FG1UT?
SPE2DR26FG1UT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FG1UT worth?
The government has obligated $16,902 on SPE2DR26FG1UT.
Is contract SPE2DR26FG1UT an order under another contract?
Yes. SPE2DR26FG1UT is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG1UT competed?
The extent of competition for SPE2DR26FG1UT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award